Sana Biotechnology, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:SANA) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 501.02 M445.47 M361.64 M435.43 M416.89 M373.59 M 負債合計 250.52 M236.39 M239.09 M240.12 M256.01 M254.35 M 純資産合計 250.5 M209.08 M122.56 M195.31 M160.88 M119.24 M 負債および純資産合計 501.02 M445.47 M361.64 M435.43 M416.89 M373.59 M 有利子負債合計 —————— 純負債 ——————

ニュース

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey (NASDAQ:SANA)

H.C. Wainwright、Sana Biotechnology株の買い推奨を継続

H.C. Wainwright reiterates Sana Biotechnology stock buy rating

モルガン・スタンレー、糖尿病データを受けてSana Biotechnology株の投資判断を維持

Morgan Stanley reiterates Sana Biotechnology stock rating on diabetes data

Sana Biotechnology、糖尿病細胞治療の14カ月データを報告

Sana Biotechnology reports 14-month data on diabetes cell therapy

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

TD Cowen、Sana Biotechnology株に買い推奨を継続

TD Cowen reiterates Buy rating on Sana Biotechnology stock

Citizensがパイプライン進展を受けてSana Biotechnology株の投資判断を維持